Dr. Rong Li's lab at George Washington University focuses on understanding how adipocytes, a type of fat cell, influence breast cancer and antitumor immunity. The research explores the roles of PD-L1 in the breast tumor microenvironment and seeks to reveal new mechanisms by which T cells respond to the tumor environment, especially in the context of obesity. By investigating these interactions, the lab aims to improve immunotherapy strategies for breast cancer, particularly for patients struggling with obesity-related health challenges.

Dr. Jeffrey Michael Bethony's lab at George Washington University focuses on improving understanding and treatment of anal cancer, particularly as it relates to individuals living with HIV. His team manages the AIDS and Cancer Specimen Resource, which collects and distributes a large number of biospecimens for research. The goal is to enhance screening, prevention, and treatment protocols through careful analysis of specimen data, ultimately benefiting public health initiatives related to HPV-associated cancers.

Dr. Jennifer Michelle Davis' lab at the University of Washington focuses on understanding how the heart adapts to stress and injury, especially concerning the roles of cardiac muscle cells and fibroblasts in heart disease. By exploring how these cells respond to mechanical and molecular changes, the lab aims to identify new therapeutic approaches to improve heart function and prevent heart failure. Her research uses innovative techniques to manipulate and understand cellular processes that contribute to cardiac health and disease.

Dr. Jeffrey Chamberlain's lab focuses on developing advanced gene therapies for Duchenne muscular dystrophy (DMD), a severe genetic disorder. The lab aims to improve the delivery and function of dystrophin proteins, utilizing innovative vector technologies. By designing new methods for gene replacement and editing, the research seeks to enhance the effectiveness and safety of treatments for DMD and related neuromuscular disorders.

Katherine B Chiappinelli's lab at George Washington University explores how certain genetic elements called LINE-1 contribute to immune evasion in ovarian cancer. They focus on understanding the mechanisms behind the expression of these elements and their effects on the tumor microenvironment. The long-term goal of this research is to uncover new potential therapies for ovarian cancer that target these immune evasion mechanisms.

Dr. Imtiaz Ahmed Khan's lab at George Washington University studies how a type of immune cell, CD4 T cells, becomes less effective during chronic infections like toxoplasmosis. They investigate the molecular mechanisms that lead to CD4 T cell exhaustion and how restoring their function could improve immunity against infections. Their research aims to develop therapies that enhance immune responses in people with weakened immune systems, particularly those suffering from conditions like HIV.

Dr. Zaid Harchaoui's lab focuses on using advanced machine learning techniques to improve brain stimulation methods for treating mental health conditions. The research aims to better understand how brain stimulation affects network dynamics in the brain and to create intelligent systems that can guide these treatments. This interdisciplinary work combines neuroscience, biostatistics, and artificial intelligence to help enhance cognitive functions such as memory and attention.

Dr. Michael Bukrinsky's lab focuses on understanding how HIV infection affects the brain, particularly in relation to neurological disorders that arise despite effective anti-retroviral treatments. They are investigating the role of a protein called Nef in disrupting cholesterol metabolism in neurons, which may contribute to cognitive impairments experienced by individuals living with HIV. The ultimate goal is to identify potential therapeutic strategies to mitigate these neurological issues and enhance the quality of life for affected patients.

Tristan Xavier Jordan's lab at the University of Washington focuses on understanding how microbial eukaryotes, particularly Acanthamoeba, defend against viral infections. By investigating the antiviral systems of these organisms, the lab aims to uncover new microbial antiviral strategies and technologies that could have significant implications for biotechnology and medicine. The research combines various advanced techniques, including protein structure prediction and metatranscriptomics, to explore the complex interactions between viruses and their eukaryotic hosts.

Dr. Luyao Lu's lab focuses on developing innovative wireless implantable devices for studying heart conditions, particularly arrhythmias and heart failure. The team creates soft, flexible systems that can monitor and influence heart activity in real-time, providing insights into the complex mechanisms underlying these diseases. Their goal is to improve diagnostic and therapeutic strategies for heart disease and enhance the quality of life for affected patients.

Dr. P. Priscilla Lui's lab at the University of Washington focuses on understanding how stressful experiences can influence young adults' use of alcohol and cannabis. By using innovative virtual reality simulations, the lab examines both direct and indirect impacts of these stressors on substance use behaviors. The ultimate goal is to identify potential strategies for prevention and treatment of substance misuse among young adults.

Dr. Sanjay B. Maggirwar's lab at George Washington University focuses on understanding how platelets contribute to the persistence of HIV infections, particularly in the brain. The research investigates viral reservoirs in the central nervous system of people living with HIV, aiming to develop strategies to eliminate these reservoirs. By studying SIV-infected rhesus macaques, the lab explores the complex interactions between the immune system and HIV, which could be crucial for finding a cure.

Dr. David Mendelowitz's lab focuses on finding new ways to combat the dangers of opioid overdose, a significant public health crisis. Specifically, they are exploring the potential of oxytocin, a hormone that is already approved for other medical uses, to prevent and treat respiratory depression caused by opioids. The lab aims to test various doses and methods of administering oxytocin in both animal models and clinical trials to assess its effectiveness before, during, and after opioid use.

Dr. Aakanksha Jain's lab focuses on understanding how the nervous system and immune system interact to influence pain and inflammation in autoimmune arthritis, particularly rheumatoid arthritis. The lab's research aims to uncover the underlying mechanisms of joint inflammation and pain, which could lead to new therapeutic approaches for managing this debilitating condition. Students will be involved in cutting-edge research that combines neuroscience and immunology, utilizing advanced techniques to explore these critical interactions.

Dr. Matthew R. Parsek's lab at the University of Washington studies how bacteria like Pseudomonas aeruginosa form biofilms and establish infections. They specifically investigate how different internal signals affect the bacteria's ability to stick to surfaces and communicate with each other. Understanding these processes can help develop new therapies for managing infections.

Dr. Payal Patel's lab at the University of Washington investigates the links between HIV and cognitive health in young adults. The research focuses on understanding how myelin, a key component of brain white matter, may be affected in individuals living with HIV, even those who are virally suppressed. This work aims to identify risks for cognitive impairment and explore potential interventions to improve brain health.

Dr. Jonathan D Posner's research lab at the University of Washington focuses on developing innovative diagnostic tools to improve healthcare delivery, specifically for hepatitis C virus (HCV) detection. The lab aims to create a point-of-care test that can quickly diagnose HCV from simple blood samples in outpatient settings, eliminating the need for complex laboratory procedures. This research has the potential to significantly enhance patient access to treatment and contribute to global health initiatives aimed at curbing hepatitis C infections.

David Baker's research lab focuses on the design and development of new protein therapeutics to tackle public health challenges, particularly in response to pandemics like COVID-19. By using advanced computational techniques, the lab aims to create small proteins that can effectively neutralize viruses and mitigate severe immune responses. This research not only targets the current health crisis but also prepares methods for rapid responses to future infectious diseases.

Dr. Lijie Grace Zhang's lab focuses on developing innovative engineering solutions to address challenges in cardiac tissue repair, particularly after heart attacks. They create advanced 3D bioprinting technologies to engineer functional myocardial tissue that can mimic the heart's natural structure and function. This research aims to improve treatment options for patients suffering from heart failure and enhance our understanding of cardiac regeneration.

Professor Bruce Trapnell's lab focuses on using advanced software tools to analyze single-cell genomics, particularly in the study of embryonic development and disease mechanisms. They work on generating and validating new datasets that provide insights into how cell types and genes function at a detailed level. By developing computational algorithms, the lab aims to better understand how genetic and environmental factors influence cell behavior in complex tissues.